Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection
Summary
Despite a robust multimodal pain management regimen, patients undergoing total knee arthroplasty (TKA) continue to report low satisfaction with postoperative pain management. Patient satisfaction further declines with any adverse event such as a drug reaction to neuroleptic medications or a patient fall due to a femoral nerve block. A new method of pain management throughout the hospital experience is warranted to improve patient satisfaction and the possibility of related adverse events. The purpose of this study is to examine if there is a difference in post operative pain and morphine (MSO4) total consumption for hospitalized TKA patients without femoral nerve block receiving an intra-operative periarticular injection of bupivacaine liposome suspension versus a concentrated multi drug.
Timeline
- Start
- 2013-08
- Primary completion
- 2013-12
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | — | Other |
| Comparator | Epinephrine | Other / unclassified | 0.6 mg | Other |
| Comparator | Ketorolac | Other / unclassified | 30 mg | Other |
| Comparator | Morphine | Other / unclassified | 5 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 400 mg | Other |
Indications
No indication recorded.